首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Percutaneous valvuloplasty for mitral valve restenosis: postballoon valvotomy patients fare better than postsurgical closed valvotomy patients.
【24h】

Percutaneous valvuloplasty for mitral valve restenosis: postballoon valvotomy patients fare better than postsurgical closed valvotomy patients.

机译:Percrusional valvuloplasty用于二尖瓣再狭窄:Postballoon Valvotomy患者的患者比后勤闭合valvotomy患者更好。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To compare the results of percutaneous mitral valvuloplasty (BMV) for mitral restenosis in post-BMV versus postclosed mitral valvotomy (CMV) patients. METHODS AND RESULTS: Ninety-two patients who underwent BMV for mitral restenosis were followed up prospectively. Of these, 28 patients had undergone previous percutaneous mitral valvuloplasty (PRIOR BMV) and 64 patients had undergone previous closed mitral valvotomy (PRIOR CMV). BMV for mitral restenosis was a success in 59% patients (57.1% PRIOR BMV, 59.3% PRIOR CMV, P = 1.0). Incidence of severe mitral regurgitation was 3.25%, all in the PRIOR CMV group. In univariate analysis, the major predictor of successful BMV for mitral restenosis was Wilkins score (P = 0.004). At a follow up of 3.47 + 2.07 years, mitral valve area was similar between groups (1.45 +/- 0.22, 1.46 +/- 0.26, P = 0.35). The combined end points of mitral valve replacement (MVR), need for re-repeat BMV for mitral restenosis or death was higher in the PRIOR CMV group (31.2% PRIOR CMV, 7.1% PRIOR BMV, P = 0.027). Event-free survival at follow up was lower in the PRIOR CMV group (69% PRIOR CMV, 92.8% PRIOR BMV) mainly due to the higher need for MVR (11 vs. 0 patients, P = 0.03). CONCLUSIONS: In conclusion, following BMV for mitral restenosis, patients with PRIOR BMV are found to have lesser event rates on follow-up compared to patients with PRIOR CMV, though procedural success rates are similar.
机译:目的:比较经皮二尖瓣成形术(BMV)与二尖瓣关闭术(CMV)后二尖瓣再狭窄的疗效。方法和结果:对92例因二尖瓣再狭窄接受BMV治疗的患者进行前瞻性随访。其中28名患者曾接受过经皮二尖瓣成形术(BMV),64名患者曾接受过二尖瓣关闭术(CMV)。BMV治疗二尖瓣再狭窄的成功率为59%(BMV前为57.1%,CMV前为59.3%,P=1.0)。严重二尖瓣反流的发生率为3.25%,均发生在先前的CMV组。在单变量分析中,威尔金斯评分(P=0.004)是成功进行BMV治疗二尖瓣再狭窄的主要预测因子。随访3.47±2.07年,两组二尖瓣面积相似(1.45+/-0.22,1.46+/-0.26,P=0.35)。二尖瓣置换术(MVR)的联合终点、二尖瓣再狭窄或死亡的再重复BMV需求在先前的CMV组中较高(31.2%先前的CMV,7.1%先前的BMV,P=0.027)。既往CMV组(69%既往CMV组,92.8%既往BMV组)的随访无事件生存率较低,主要是因为对MVR的需求较高(11名患者与0名患者,P=0.03)。结论:总之,BMV治疗二尖瓣再狭窄后,既往BMV患者的随访事件发生率低于既往CMV患者,尽管手术成功率相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号